CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shenzhen Neptunus Interlong Bio-technique Co Ltd Company Snapshot
Shenzhen Neptunus Interlong Bio-technique Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shenzhen Neptunus Interlong Bio-technique Co Ltd with three other companies in this sector in China: Autobio Diagnostics Co Ltd (2015 sales of 716.48 million Chinese Renmimbi [US$104.10 million] ), Shanghai Fudan Forward S&T Co Ltd (715.69 million Chinese Renmimbi [US$103.98 million] of which 59% was Industrial), and Ginwa Enterprise Group Inc. (727.82 million Chinese Renmimbi [US$105.74 million] of which 52% was Pharmaceutical Industry).

Sales Analysis. During the year ended December of 2015, sales at Shenzhen Neptunus Interlong Bio-technique Co Ltd were 721.35 million Chinese Renmimbi (US$104.80 million). This is an increase of 11.3% versus 2014, when the company's sales were 648.27 million Chinese Renmimbi. This was the fifth consecutive year of sales increases at Shenzhen Neptunus Interlong Bio-technique Co Ltd (and since 2010, sales have increased a total of 1,786%). Sales of Purchase and Sales of Medicines and Health saw an increase that was more than double the company's growth rate: sales were up 93.1% in 2015, from 137.18 million Chinese Renmimbi to 264.85 million Chinese Renmimbi. Not all segments of Shenzhen Neptunus Interlong Bio-technique Co Ltd experienced an increase in sales in 2015: sales of Research and Development Services fell 94.3% to 63,000.00 Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). Shenzhen Neptunus Interlong Bio-technique Co Ltd also experienced decreases in sales in Manufacturing and Selling Medicine Products (down 10.5% to 456.43 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shenzhen Neptunus Interlong Bio-technique Co Ltd
  Stock Performance Chart for Shenzhen Neptunus Interlong Bio-technique Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): .42
(Figures in Chinese Renmimbi)
1 Week 1.9%   13 Weeks -3.9%  
4 Weeks -3.0%   52 Weeks -15.9%  
 
Shenzhen Neptunus Interlong Bio-technique Co Ltd Key Data:
  Ticker: 8329 Country: China
  Exchanges: HKG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 721,346,000
(Year Ending Jan 2016).
Employees: 1,426
  Currency: Chinese Renmimbi Market Cap: 699,222,600
  Fiscal Yr Ends: December Shares Outstanding: 1,678,000,000
  Share Type: H Gu Closely Held Shares: N/A
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.